|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pulford DJ, Falls JG, Killian JK and
Jirtle RL: Polymorphisms, genomic imprinting and cancer
susceptibility. Mutat Res. 436:59–67. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galvani E, Peters GJ and Giovannetti E:
EGF receptor-targeted therapy in non-small-cell lung cancer: role
of germline polymorphisms in outcome and toxicity. Future Oncol.
8:1015–1029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Habbous S, Pang V, Eng L, et al: p53
Arg72Pro polymorphism, HPV status and initiation, progression and
development of cervical cancer: a systematic review and
meta-analysis. Clin Cancer Res. 18:6407–6415. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herold K, Moser B, Chen Y, Zeng S, Yan SF,
Ramasamy R, Emond J, Clynes R and Schmidt AM: Receptor for advanced
glycation end products (RAGE) in a dash to the rescue: Inflammatory
signals gone awry in the primal response to stress. J Leukoc Biol.
82:204–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brett J, Schmidt AM, Yan SD, et al: Survey
of the distribution of a newly characterized receptor for advanced
glycation end products in tissues. Am J Pathol. 143:1699–1712.
1993.PubMed/NCBI
|
|
7
|
Bartling B, Hofmann HS, Weigle B, Silber
RE and Simm A: Down-regulation of the receptor for advanced
glycation end-products (RAGE) supports non-small cell lung
carcinoma. Carcinogenesis. 26:293–301. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Englert JM, Hanford LE, Kaminski N, et al:
A role for the receptor for advanced glycation end products in
idiopathic pulmonary fibrosis. Am J Pathol. 172:583–591. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuniyasu H, Oue N, Wakikawa A, Shigeishi
H, Matsutani N, Kuraoka K, Ito R, Yokozaki H and Yasui W:
Expression of receptors for advanced glycation end-products (RAGE)
is closely associated with the invasive and metastatic activity of
gastric cancer. J Pathol. 196:163–170. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fuentes MK, Nigavekar SS, Arumugam T,
Logsdon CD, Schmidt AM, Park JC and Huang EH: RAGE activation by
S100P in colon cancer stimulates growth, migration, and cell
signaling pathways. Dis Colon Rectum. 50:1230–1240. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsieh HL, Schäfer BW, Sasaki N and
Heizmann CW: Expression analysis of S100 proteins and RAGE in human
tumors using tissue microarrays. Biochem Biophys Res Commun.
307:375–381. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sparvero LJ, Asafu-Adjei D, Kang R, et al:
RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands,
and their role in cancer and inflammation. J Transl Med. 7:172009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tesarová P, Kalousová M, Jáchymová M,
Mestek O, Petruzelka L and Zima T: Receptor for advanced glycation
end products (RAGE) - soluble form (sRAGE) and gene polymorphisms
in patients with breast cancer. Cancer Invest. 25:720–725. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schenk S, Schraml P, Bendik I and Ludwig
CU: A novel polymorphism in the promoter of the RAGE gene is
associated with non-small cell lung cancer. Lung Cancer. 32:7–12.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Cui E, Zeng H, Hua F, Wang B, Mao
W and Feng X: RAGE genetic polymorphisms are associated with risk,
chemotherapy response and prognosis in patients with advanced
NSCLC. PLoS ONE. 7:e437342012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mountain CF: A new international staging
system for lung cancer. 1986. Chest. 136:(Suppl).
e252009.PubMed/NCBI
|
|
17
|
World Medical Association, . World Medical
Association Declaration of Helsinki-Ethical Principles for Medical
Research Involving Human Subjects. http://www.wma.net/en/30publications/10policies/b3/index.htmlAccessed.
March 11–2015
|
|
18
|
Lehr HA, Mankoff DA, Corwin D, et al:
Anpplication of photoshop-based image analysis to quantification of
hormone receptor expression in breast cancer. J Histochem Cytochem.
45:1559–1565. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Wang H, Piper MG, et al: sRAGE
induces human monocyte survival and differentiation. J Immunol.
185:1822–1835. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Beránek M, Kanková K, Kolár P and Znojil
V: Polymorphisms in the von Willebrand factor gene are not
associated with proliferative retinopathy in non-insulin-dependent
diabetes mellitus. Ophthalmic Res. 34:327–330. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanková K, Márová I, Záhejský J, Muzík J,
Stejskalová A, Znojil V and Vácha J: Polymorphisms 1704G/T and
2184A/G in the RAGE gene are associated with antioxidant status.
Metabolism. 50:1152–1160. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tam XH, Shiu SW, Leng L, Bucala R,
Betteridge DJ and Tan KC: Enhanced expression of receptor for
advanced glycation end-products is associated with low circulating
soluble isoforms of the receptor in Type 2 diabetes. Clin Sci
(Lond). 120:81–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bopp C, Hofer S, Weitz J, Bierhaus A,
Nawroth PP, Martin E, Büchler MW and Weigand MA: sRAGE is elevated
in septic patients and associated with patients outcome. J Surg
Res. 147:79–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu X, Chen Q, Shi S, Shi Z, Lin R, Tan L,
Yu J, Shu Q and Fang X: Plasma sRAGE enables prediction of acute
lung injury after cardiac surgery in children. Crit Care.
16:R912012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Garber ME, Troyanskaya OG, Schluens K, et
al: Diversity of gene expression in adenocarcinoma of the lung.
Proc Natl Acad Sci USA. 98:13784–13789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jabaudon M, Futier E, Roszyk L, et al:
Soluble form of the receptor for advanced glycation end products is
a marker of acute lung injury but not of severe sepsis in
critically ill patients. Crit Care Med. 39:480–488. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Piperis M, Provatopoulou X, Sagkriotis A,
Kalogera E, Ampatzoglou E, Zografos GC, Athanasiou E and Gounaris
A: Effect of breast cancer adjuvant therapies on potential
biomarkers of pulmonary inflammation. Anticancer Res. 32:4993–5002.
2012.PubMed/NCBI
|
|
28
|
Fujisawa K, Katakami N, Kaneto H, et al:
Circulating soluble RAGE as a predictive biomarker of
cardiovascular event risk in patients with type 2 diabetes.
Atherosclerosis. 227:425–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
